TrialBioMed research international2020

Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age.

Maurizio Battaglia Parodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.